Esperion to Participate in Upcoming Piper Sandler 36th Annual Healthcare Conference

Rhea-AI Summary

Esperion (NASDAQ: ESPR) has announced its participation in the Piper Sandler 36th Annual Healthcare Conference scheduled for Thursday, December 5, 2024, at 12:30 p.m. ET. The event will be webcasted and accessible through Esperion's investor and media section website, with replay available approximately two hours after completion and archived for 90 days.

Esperion focuses on developing innovative medicines for cardiovascular and cardiometabolic diseases, particularly targeting high cholesterol. The company aims to support healthcare providers in reducing LDL-cholesterol levels effectively, addressing the needs of millions of patients whose health requirements are not met by current standards.

News Market Reaction – ESPR

+2.49%

+2.49% Session move

In the trading session that priced this news, ESPR gained 2.49%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

ANN ARBOR, Mich., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that the company will be participating in the webcasted 2024 Piper Sandler 36^th Annual Healthcare Conference on Thursday, December 5, 2024, at 12:30 p.m. ET.

The live webcast can be accessed on the investor and media section of the Esperion website. Access to the webcast replay will be available approximately two hours after the completion of the call and will be archived on the Company’s website for approximately 90 days.

Esperion Therapeutics
At Esperion, we discover, develop, and commercialize innovative medicines to help improve outcomes for patients with or at risk for cardiovascular and cardiometabolic diseases. The status quo is not meeting the health needs of millions of people with high cholesterol – that is why our team of passionate industry leaders is breaking through the barriers that prevent patients from reaching their goals. Providers are moving toward reducing LDL-cholesterol levels as low as possible, as soon as possible; we provide the next steps to help get patients there. Because when it comes to high cholesterol, getting to goal is not optional. It is our life’s work. For more information, visit esperion.com and esperionscience.com and follow us on X at twitter.com/EsperionInc.

Esperion Contact Information:
Investors:
Alina Venezia
investorrelations@esperion.com
(734) 887-3903

Media:
Tiffany Aldrich
corporateteam@esperion.com
(616) 443-8438

FAQ

When is Esperion (ESPR) presenting at the Piper Sandler Healthcare Conference 2024?

Esperion (ESPR) is presenting at the Piper Sandler Healthcare Conference on Thursday, December 5, 2024, at 12:30 p.m. ET.

How long will Esperion's (ESPR) webcast replay be available?

The webcast replay will be archived on Esperion's website for approximately 90 days, with access available about two hours after the presentation ends.

What is Esperion's (ESPR) main focus in healthcare?

Esperion focuses on discovering, developing, and commercializing innovative medicines for patients with cardiovascular and cardiometabolic diseases, particularly targeting high cholesterol management.

How can investors access Esperion's (ESPR) Piper Sandler conference presentation?

Investors can access the live webcast through the investor and media section of Esperion's website.